Pseudomonas Aeruginosa
Showing 26 - 34 of 34
Cystic Fibrosis, Pseudomonas Aeruginosa Trial in Tübingen, Jena (Tobramycin (Gernebcin®))
Completed
- Cystic Fibrosis
- Pseudomonas Aeruginosa
- Tobramycin (Gernebcin®)
-
Tübingen, Baden-Würtemberg, Germany
- +1 more
Dec 3, 2014
Volatile Organic Compounds in Cystic Fibrosis
Completed
- Cystic Fibrosis
- Pseudomonas Aeruginosa
- Cystic Fibrosis patients
-
Ventura, CaliforniaPediatric Diagnostic Center
Aug 12, 2014
Cystic Fibrosis, Pseudomonas Aeruginosa Trial in Worldwide (AZLI)
Completed
- Cystic Fibrosis
- Pseudomonas Aeruginosa
-
Aurora, Colorado
- +28 more
May 12, 2014
Cystic Fibrosis, Pseudomonas Aeruginosa Trial in Tübingen, Jena, Hamburg (Colistin)
Completed
- Cystic Fibrosis
- Pseudomonas Aeruginosa
-
Tübingen, Baden-Würtemberg, Germany
- +2 more
Mar 20, 2013
Cystic Fibrosis, Pseudomonas Aeruginosa Trial in Canada (Aztreonam lysine)
Approved for marketing
- Cystic Fibrosis
- Pseudomonas Aeruginosa
- Aztreonam lysine
-
Calgary, Alberta, Canada
- +3 more
Dec 12, 2012
Cystic Fibrosis, Lung Infection, Pseudomonas Aeruginosa Trial in Australia, Canada, United States (AZLI 75 mg three times daily
Completed
- Cystic Fibrosis
- +2 more
- AZLI 75 mg three times daily (TID)
- Placebo three times daily (TID)
-
Phoenix, Arizona
- +39 more
Nov 19, 2010
Cystic Fibrosis, CF, Lung Infection Trial in United States (Aztreonam for Inhalation (AI), Placebo)
Completed
- Cystic Fibrosis
- +3 more
- Aztreonam for Inhalation (AI)
- Placebo
-
Los Angeles, California
- +19 more
Jan 25, 2010
Pseudomonas Aeruginosa, Ventilator Associated Pneumonia Trial in Multiple Cities (KB001, Placebo)
Completed
- Pseudomonas Aeruginosa
- Ventilator Associated Pneumonia
- KB001
- Placebo
-
Multiple Cities, France(unnamed)
Jul 29, 2009
Cystic Fibrosis, Infection, Pseudomonas Aeruginosa Trial in Tuebingen (amitriptyline)
Completed
- Cystic Fibrosis
- +2 more
-
Tuebingen, Baden-Wuerttemberg, GermanyUniversity of Tuebingen
Aug 10, 2007